Mucinous breast cancer: A narrative review of the literature and a retrospective tertiary single-centre analysis.

Authors :: Marrazzo E
Frusone F
Milana F
Sagona A
Gatzemeier W
Barbieri E
Bottini A
Canavese G
Rubino AO
Eboli MG
Rossetti CM
Testori A
Errico V
De Luca A
Tinterri C
Source :: Breast (Edinburgh, Scotland) [Breast] 2020 Feb; Vol. 49, pp. 87-92. Date of Electronic Publication: 2019 Nov 11.
Publication Year :: 2020
Abstract: Mucinous carcinoma (MC) is a rare breast cancer characterized by the presence of large extracellular mucin amount. Two main subtypes can be distinguished: pure (PMC) and mixed (MMC). We conducted a retrospective MC analysis in our prospective maintained database, calculating disease-free survival (DFS) and 5-year overall survival (OS). We found a global 92.1% OS (higher in MMC group and statistically significative) and a DFS of 95.3% (higher in MMC group but not statistically significative).<br />Competing Interests: Declaration of competing interest The authors declare that they have no conflict of interest in relation to this work.<br /> (Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Full Text Access

Tools